Introduction SEAVDRAC. 23 October Prof G E Swan. Southern and Eastern African Veterinary Drug Regulatory Affairs conference

Similar documents
All medicinal products (for human and veterinary use) are regulated under the single Pharmaceutical Act.

14th Conference of the OIE Regional Commission for Africa. Arusha (Tanzania), January 2001

OIE Conference on Veterinary Medicinal Products in the Middle East

Dr. Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

Dr A T Sigobodhla. Regional Workshop for OIE National Focal Points for Veterinary Products (Cycle V): Ezulwini, Swaziland, 6-8 December 2017

Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP Adopted 2005

Antimicrobial resistance. Summary of OIE Activities

Support for OIE Member Countries OIE PVS / Gap Analysis, Reference Laboratories and twinning programmes

OIE Strategy for Veterinary Products and Terms of Reference for the OIE National Focal Points

Contents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department

VICH:Organization,Guidelines and Global Outreach

OIE Resolution and activities related to the Global Action Plan. Regional Seminar for OIE National Focal Points for Veterinary Products 4 th Cycle

Legislation, Registration and Control Procedures for Veterinary Medicinal Products in the European Union

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

international news RECOMMENDATIONS

Mutual Recognition of Immunological Veterinary Products in East Africa. NOEL AINEPLAN National Drug Authority Uganda

The OIE Relevant Standards and Guidelines for Veterinary Medicinal Products

RECENT ACTIVITIES OF THE NATIONAL FOCAL POINT FOR VETERINARY PRODUCTS - SWAZILAND PRESENTATION TO

EU strategy to fight against Antimicrobial Resistance

International Harmonisation in the Field of Pharmacovigilance from an OIE perspective

Recognition of Export Controls and Certification Systems for Animals and Animal Products. Guidance for Competent Authorities of Exporting Countries

Dr Dooshima Kwange Department of Veterinary and Pest Control Services FMARD

and suitability aspects of food control. CAC and the OIE have Food safety is an issue of increasing concern world wide and

The OIE Relevant Standards and Guidelines for Vaccines

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE

OIE Activities for the Containment of Antimicrobial Resistance. Dr Elisabeth Erlacher-Vindel, Deputy Head of the Scientific and Technical Department

Overview of the OIE PVS Pathway

Antimicrobial resistance: the challenges for animal health

Assessment of compliance of current legislation: Veterinary Products Act

Council of the European Union Brussels, 13 June 2016 (OR. en)

OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I

OIE Standards on Veterinary Legislation: Chapter 3.4 of the OIE Terrestrial Animal Health Code

Prudent use of antimicrobial agents Dairy Sector Initiatives. Robin Condron Dairy Australia

Private Sector Perspectives IFAH (worldwide)

Transmitted by Co-Chairs of the Informal Working Party On Periodical Technical Inspections. WP (08-11 March 2016, agenda item 7.

FAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR)

VICH :To a wider international harmonisation of registration requirements

International approach for veterinary medicinal products: OIE and Codex alimentarius

Promoting One Health : the international perspective OIE

Dr Stuart A. Slorach

The PVS Tool. Part 4. Introduction to the concept of Fundamental Components and Critical Competencies

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

COMMISSION OF THE EUROPEAN COMMUNITIES

General Directorate of Animal Health and EpizooticDiseases Control. Dr.Sabah Hassan Abdelgadir Sudan Focal Point for Veterinary products

Counterfeit drugs: Experience of West Africa

National Action Plan development support tools

OIE PVS Pathway including Veterinary Education

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

OIE strategy on AMR and the Prudent Use of Antimicrobials

OIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents

OIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents

The OIE activities to protect animal and human health: Potential contributions in the fight against counterfeit drugs

21st Conference of the OIE Regional Commission for Europe. Avila (Spain), 28 September 1 October 2004

All participants at the Salt Lake City confirmed strong support for the OIE assuming an international laboratory animal welfare role.

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 13 to 15 July 2004

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

Review of requirements and processes for registration of veterinary products in selected African and Asian countries

Quality of veterinary medicines

Managing AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan

Results of the questionnaire on Veterinary Medicinal Products in the Middle East Damascus, Syria, 2-4 December 2009

Draft ESVAC Vision and Strategy

CHAPTER 3.3. VETERINARY LEGISLATION

The impact of Good Veterinary Services Governance (GVSG) on the control over Veterinary Medicinal Products (VMP s)

Action for Combatting AMR in Veterinary Sector

Role and responsibilities of the veterinarian in the aquatic sector The OIE perspective

OIE capacity-building activities

RESIDUE MONITORING AND CONTROL PROGRAM. Dr. T. Bergh Acting Director: Veterinary Public Health Department Agriculture, Forestry and Fisheries

The promise of aquaculture and the challenge of antimicrobial use

OIE mission in the framework of One Health Focus on antimicrobial resistance (AMR)

World Organisation for Animal Health

Outline of Risk Analysis for Veterinary Vaccines in Japan

OIE Standards for: Animal identification and traceability Antimicrobials

Global capacity for sustainable surveillance of emerging zoonoses

of Conferences of OIE Regional Commissions organised since 1 June 2008

OIE standards on the use of antimicrobials and antimicrobial resistance monitoring

GLOBAL PERSPECTIVES ON ANTIMICROBIAL RESISTANCE IN THE FOOD CHAIN. Sarah M Cahill, Patricia Desmarchelier, Vittorio Fattori, Andrew Cannavan

The OIE-PVS: a tool for good Governance of Veterinary Services

OIE AMR Strategy, One Health concept and Tripartite activities

Policy on Community-based Animal Health Workers

Introduction Coordinating surveillance policies in animal health and food safety from farm to fork

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

Good governance and the evaluation of Veterinary Services

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

Illegal veterinary drugs. How to ensure the quality and traceability of Veterinary Medicinal Products

Responsible Use of Veterinary Products. Bettye K. Walters, DVM

Benson Ameda President of the Association of Veterinary Technicians in Africa

Veterinary Education in Africa

V E T E R I N A R Y C O U N C I L O F I R E L A N D ETHICAL VETERINARY PRACTICE

INTERNATIONAL AND NATIONAL COORDINATION IN STANDARD SETTING

OIE Collaborating Centres Reports Activities

The Commission activities on AMR (focus on zoonotic issues)

The Integration of WTO Agreements into National Legislation: Case of the SPS Agreement

Implications for Registration and Approval of Innovative Technologies

Terrestrial and Aquatic Manuals OIE Standard Setting Process

Office International des Épizooties World Organisation for Animal Health created in 1924 in Paris

Human Food Safety of Veterinary Drugs. Bettye K. Walters, DVM

Transcription:

23 October 2010 Prof G E Swan 1 Introduction Ghana; Kenya; Mauritius; Mozambique; Namibia; Nigeria; South Africa; Tanzania; Uganda; Zimbabwe Southern and Eastern African Veterinary Drug Regulatory Affairs conference inaugural a meeting occurred in 1997 with support of OIE Follows SEAMRAC and Search regional harmonisation initiatives Attended by 26 delegates from 11 countries in Africa 2 1

Program of 1 st meeting of Theme 1: Legislation and Regulatory Aspects Theme 2: Veterinary drug and Biological Regulatory Procedures Theme 3: Registration process Technical Requirements Theme 4: Manufacture, Importation and Risk Assessment Theme 5: Distribution and Use Theme 6: Pharmacovigilance and Monitoring Theme 7: Liaison and Co-Operation with industry Theme 8: Harmonisation 3 Resolutions of 1 st meeting of 1. Undertakes to be recognized as the representative body of the drug regulatory authorities concerned with veterinary products within the region 2. Requests to be included in the consultative process of VICH 3. Investigates the feasibility of establishing uniform or alternatively centralized regulatory procedures to this purpose the congress proposes that a working committee be established to prepare recommendations for these procedures for consideration at the next conference 4 2

Resolutions of 1 st meeting of 4. Crafts a standard application form and a standard format for application dossier within the participating i countries 5. Encourages training of officials from drug registration authorities in the fields of e.g. quality assurance, inspections, evaluation of application dossiers this training should be sought from regional and international bodies 6. Encourages member countries to establish an inventory of available expertise, human and facility or laboratory resources, and data bases or networking that which may be shared among countries 5 Resolutions of 1 st meeting of 7. Encourages the drug regulatory authorities of member countries to exchange information on technical aspects, systems and data from pharmacovigilance of registered products; 8. Encourages the establishment and/or harmonisation of existing conflicting national legislation 9. Encourages the formation of representative industry associations iti in this region 10. Encourages industry to undertake local research and development bearing in mind the unique disease conditions and wildlife resources in Africa 6 3

Resolutions of 1 st meeting of 11. Undertakes liaison with SEAMRAC 12. Encourages other regions within Africa to take similar initiatives and promotes cooperation in the various regions 13. That a follow-up meeting will take place in one year of this meeting 7 Resolutions 2 nd Conference, 1. Recognising the increasing extent of counterfeit medicines, repacking and use of homebrew formulations and accepting that there are dangers to the practices to human and animal haltht health, to recommend to government to bring these practices to the attention of the relevant law enforcement authorities with the recommendation that adequate resources be used to combat these practices 2. Taking cognisance that the numbers and diversity of regulatory systems leads to unnecessary duplication in the evaluation and approval of veterinary medicinal products recommends that governments embark on a course of harmonising licensing and registration systems. 8 4

Resolutions 2 nd Conference, 3. To develop procedure(s) (e.g. training) assuring greater awareness of international standards regarding Maximum Residue Limits for food animals and their products for applicationati at the nationalnal and international level 4. Provide, as appropriate, training modules on risk analysis regarding veterinary medicines to facilitate compliance with Codex alimentarius standards for food animals and their products 5. Assist African nations by making provision for relevant documents at the international level on the quality management systems for laboratories to control residues of veterinary drugs in food and risk assessment procedures 9 Resolutions 2 nd Conference, 6. Improve awareness for producers and consumers to potential public health issues with regard to residues of veterinary drugs in field 7. To harmonise and apply measures consistent with international standards (e.g. Codex) with regard to residues of veterinary drugs in food 8. To investigate the possibility of creating and maintaining a Web- Site for for exchange of information, reporting of adverse reactions and for the listing of standardized procedures and guidelines. 9. To develop standard technical guidelines within the southern and eastern African region for the prudent use of antimicrobials in animals. 10 5

Resolutions 2 nd Conference, 10. To implement appropriate monitoring of antimicrobial usage within the southern and eastern African region in accordance with the guidelines sdvl developed pdby the O.I.E. 11. To develop a harmonised programme for the monitoring and surveillance of antimicrobial resistance in southern and eastern African region in accordance with the guidelines developed by the O.I.E.. 12. Acceptance of a single, internationally acceptable standard (e.g. VICH guidelines) for stability, clinical studies, GMP etc.. 13. Standardise di on number of drug samples required by regulatory authorities. 11 Resolutions 2 nd Conference, 14. Taking into account that the responsibility that is vested in the Department of Health to control medicines and the responsibility of the Department of Agriculture to ensure the safety and security and the availability of veterinary products to the community to encourage governments to include both the Minister of Agriculture and the Minister of Health to act jointly in the regulation and control of veterinary medicinal products 15. To develop regional guidelines for technical requirements for the market authorisation of new pharmaceutical entities, generic compounds and biologicals 16. Accepting the need for the production and sale of quality veterinary medicinal products and the national accreditation of manufacturing and laboratory facilities to recommend that governments institute internationally accredited quality inspection systems 12 6

Resolutions 2 nd Conference, 18. To follow up on the proposal of His Excellency The Minister of Medical Services Dr Anangwe, to facilitate at interministerial level, possibly through a conference, a recommendation to advance communication by electronic means on regulation of human and veterinary medicines between the countries party to the conference. Such communication aims to facilitate the harmonisation of authorisation procedures by advancing a mutual understanding and recognition between the countries concerned to ensure the provision of adequate, safe, high quality medicines in southern and eastern Africa 19. This conference recognising the need for post registration pharmacovigilance reporting methodology encouraging member countries to cooperate in the transfer of data between authorities recognising the need for safe Veterinary Medicinal Products 13 Resolutions 2 nd Conference, 20. This conference proposes that three working groups, viz. Registration, Legislation and Drug Control, be formed to develop harmonized Guidelines and Procedures on the topical areas as identified 21. Training in biological evaluation and standards for development should be encouraged. For example individual countries regulatory authorities should consider the utilization of biologics training programmes such as IICAB 14 7

Conclusion Need and importance of harmonization had very good start but could not be sustained due to lack of political l support Resolutions taken remain very relevant today served as an excellent opportunity for technical and operational staff involved in drug regulatory matters for communication and exchange of ideas Harmonization is a step-wise process whereby operational procedures are more easily achieved than technical agreements 15 8